Cogent Biosciences, Inc. COGT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$97.35M-35.2% | -$102.49M-50.9% | -$80.93M-14.6% | -$73.53M-24.7% | -$71.99M-23.4% | ||
| $626K-2.2% | $628K+0.5% | $641K+3.4% | $655K+8.1% | $640K+6.8% | ||
| $16.91M+68.9% | $15.75M+57.9% | $10.6M+2.4% | $9.72M-3.0% | $10.01M+6.5% | ||
| -$86.88M-30.6% | -$79.11M-30.6% | -$64.29M-23.7% | -$54.54M-27.7% | -$66.51M-26.6% | ||
| $449K-17.9% | $811K+981% | $65K-76.8% | $131K-11.5% | $547K+681% | ||
| -$36.46M-153% | -$322.77M-623% | -$155.05M-358% | $8.91M+111% | $69.38M+6,545% | ||
| —— | $13.66M— | $13.66M— | $13.66M— | $13.66M— | ||
| $52.54M+110% | $588.67M+2,264,012% | $217.37M+34,734% | $47.23M— | $24.97M-88.3% | ||
| -$70.8M-354% | $186.8M+16,578% | $0-100% | $1.6M— | $27.84M-82.9% | ||
| -$87.33M-30.2% | -$79.92M-31.8% | -$64.35M-23.1% | -$54.67M-27.6% | -$67.06M-27.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cogent Biosciences, Inc. generate?
- Cogent Biosciences, Inc. (COGT) generated -$284.8M in operating cash flow over the trailing twelve months.
- What is Cogent Biosciences, Inc.'s free cash flow?
- After $1.5M of capital expenditures, Cogent Biosciences, Inc.'s free cash flow was -$286.3M over the trailing twelve months, down 28.5% year over year.
- Where does Cogent Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
